type 2 diabetes
New Actos suits go straight to MDL
- Fri, 06/29/2012 - 3:21pm
New lawsuits against Takeda Pharmaceuticals’ Type 2 diabetes drug Actos can move straight to the Multidistrict Litigation case thanks to a
Cleveland Clinic links diabetes drugs with increased death risk
- Fri, 06/29/2012 - 2:38pm
Diabetes drugs glipizide, glyburide and glimepiride have recently been associated with a more than 50 percent higher mortality ri
Actos' role in blindness and bladder cancer
- Thu, 06/14/2012 - 3:11pm
Recent studies reveal that thiazolidinediones like pioglitazone (Actos) and rosiglitazone (Avandia) pose both an increased
Diabetes Drug Could Increase Risk of Blindness
- Thu, 06/14/2012 - 10:56am
Johnson & Johnson's type 2 diabetes drug trumps Januvia
- Mon, 06/11/2012 - 3:53pm
According to data from five late stage clinical studies, Johnson & Johnson’s new anti-diabetic drug canagliflozin decreased blood sugar by a significant amount when compared to alternative trea